|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, January 25, 2020 ) According to a new market research report “𝐑𝐚𝐝𝐢𝐨𝐭𝐡𝐞𝐫𝐚𝐩𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 by Product (Radiotherapy Devices, Software, Service), Procedure (EBRT, Brachytherapy, Systemic Radiotherapy), Technology (IMRT, SRT, VMAT, HDRBT, LDRBT, PDRBT), Application (Prostate, Breast) - Global Forecast to 2025”, published by Meticulous Research®, the global radiotherapy market is expected to grow at a CAGR of 5.6% from 2019 to reach $10.15 billion by 2025.
The growing awareness about the benefits of radiotherapy for cancer control and eradication, increasing incidence & prevalence of cancer, and technological advancements in the field of radiotherapy are the key factors driving steady growth of the overall radiotherapy market.
𝐑𝐞𝐪𝐮𝐞𝐬𝐭 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭: https://www.meticulousresearch.com/download-sample-report/cp_id=5023
According to GLOBOCAN, in 2012, about 14.1 million new cancer cases were diagnosed across the globe, which increased by ~28% to reach 18.1 million new cases in 2018. Further, these numbers are expected to rise by ~110% to 29.5 million cases by 2040. Therefore, with increase in the volume of cancer patients globally, the number of radiotherapy procedures performed is growing rapidly. Due to this increase, the number of radiotherapy equipment installations is also increasing simultaneously. For instance, according to the American Association for Cancer Research (AACR), the demand for radiotherapy procedures has increased steadily over the past decade. According to the estimates, in the U.S., 3.05 million patients received radiation therapy in 2016, which is expected to increase by ~37%, reaching 4.17 million by 2040.
The radiotherapy market study presents historical market data in terms of value (2017, and 2018), estimated current data (2019), and forecasts for 2025 - by product, procedure, technology, application, end user, and region. The study also evaluates industry competitors and analyzes the market at a regional and country level.
Based on product type, the radiotherapy devices segment is estimated to account for the largest share of the overall radiotherapy market in 2019. The large share of this segment is mainly attributed to increasing installations of radiotherapy systems, globally with the rising demand for radiotherapy procedures for cancer treatment and new product launches with advanced technologies.
Based on procedure, external beam radiotherapy segment is poised to account for the largest share of the overall radiotherapy market in 2019 and is also expected to witness the highest growth during the forecast period. The large adoption of this procedure segment is mainly attributed to better clinical outcomes, high specificity towards tumor cells, and continuous advancements in external beam radiotherapy procedures.
Based on technology, the external beam radiotherapy market is classified into IMRT, IGRT, SRT, 3DCRT, Particle Therapy, and VMAT. The particle beam therapy segment is projected to grow at the highest CAGR during the next 5-6 years, mainly due to continuous innovations in the particle beam therapy technologies, increasing availability of advanced proton therapy systems, and increasing investment in the proton therapy room across the globe.
𝐒𝐩𝐞𝐚𝐤 𝐭𝐨 𝐎𝐮𝐫 𝐄𝐱𝐩𝐞𝐫𝐭 𝐀𝐧𝐚𝐥𝐲𝐬𝐭: https://www.meticulousresearch.com/speak-to-analyst/cp_id=5023
Based on application, the prostate cancer segment is projected to grow at the highest CAGR during the forecast period, mainly due to rising incidence of prostate cancer and related mortality, growing diagnosis and treatment rate of the disease, and increasing awareness about the fatality and benefits of early diagnosis and treatment across the globe.
Based on end user, the hospitals segment accounted the largest share of the global market, mainly due to large volume of patient admissions in hospitals for treatment of cancer and higher affordability of hospitals for high cost medical devices.
The report also includes extensive assessment of the key strategic developments adopted by the leading market participants in the industry over the past 4 years (2016–2019). The radiotherapy market has witnessed number of product launches and approvals in recent years. For instance, in December 2018, Elekta AB (Sweden) received approval of Elekta Unity magnetic resonance radiation therapy (MR/RT) system. Similarly, in June 2017, Varian Medical Systems, Inc. received FDA 510(k) clearance for its Halcyon system, which offers advanced treatments for prostate, breast, head & neck, and many other forms of cancer.
The radiotherapy market is highly competitive with the presence of several small and large players. The key players operating in the global radiotherapy market are Varian Medical Systems, Inc., Elekta AB, Accuray Incorporated, C. R. Bard, Inc., Mevion Medical Systems, Inc., Hitachi, Ltd., ViewRay, Inc., Panacea Medical Technologies Pvt. Ltd., Isoray, Inc., Optivus Proton Therapy, Inc., P-Cure, Ltd., Provison Healthcare, LLC, Ion Beam Applications S.A., and Theragenics Corporation among others.
𝐁𝐫𝐨𝐰𝐬𝐞 𝐤𝐞𝐲 𝐢𝐧𝐝𝐮𝐬𝐭𝐫𝐲 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐬𝐩𝐫𝐞𝐚𝐝 𝐚𝐜𝐫𝐨𝐬𝐬 𝟒𝟎𝟑 𝐩𝐚𝐠𝐞𝐬 𝐰𝐢𝐭𝐡 𝟑𝟕𝟔 𝐦𝐚𝐫𝐤𝐞𝐭 𝐝𝐚𝐭𝐚 𝐭𝐚𝐛𝐥𝐞𝐬 & 𝟖𝟔 𝐟𝐢𝐠𝐮𝐫𝐞𝐬 & 𝐜𝐡𝐚𝐫𝐭𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐫𝐞𝐩𝐨𝐫𝐭: https://www.meticulousresearch.com/product/radiotherapy-market-5023/
𝐒𝐜𝐨𝐩𝐞 𝐨𝐟 𝐭𝐡𝐞 𝐑𝐞𝐩𝐨𝐫𝐭:
Market by Procedure
External Beam radiotherapy
Linear Accelerator based Teletherapy
Cobalt-60 based teletherapy
Proton Therapy
Internal Beam Radiotherapy
Brachytherapy
Systemic Radiotherapy
Market by Product
Radiotherapy Devices
External beam radiotherapy systems
Conventional Linear Accelerators (LINAC)
Conventional Cobalt-60 Teletherapy units
Advanced Stereotactic Radiotherapy Units (Linear Accelerator/Cobalt- 60 unit)
Cyberknife
Gamma knife
Tomotherapy
Proton Therapy Systems
Cyclotron
Synchrotron
Synchrocyclotron
Internal Beam radiotherapy systems
Brachytherapy
Afterloaders
Electronic Brachytherapy products
Radiotherapy Consumables & Accessories
External beam radiotherapy
Cobalt-60 Source
Others
Internal Beam Radiotherapy
Brachytherapy
Brachytherapy Applicators
Brachytherapy seeds
Systemic Radiotherapy
Iobenguane
Samarium-153
Rhenium-186
Others
Software
Services
Market by Technology
External Beam Radiotherapy
Intensity-Modulated Radiation Therapy (IMRT)
Image-guided Radiation Therapy (IGRT)
Stereotactic Radiation Therapy
3D Conformal Radiation Therapy
Particle Therapy
Volumetric Modulated Arc Therapy (VMAT)
Internal Beam Radiotherapy
Brachytherapy
High Dose Rate Brachytherapy (HDR)
Low Dose Rate Brachytherapy (LDR)
Image-guided Brachytherapy (IGBT)
Pulse Dose Rate Brachytherapy (PDR)
Systemic Radiation Therapy
Intravenous radiotherapy
Oral Radiotherapy
Market by Application
Prostate Cancer
Brain Tumor
Breast Cancer
Lung Cancer
Head & Neck Cancer
Colorectal Cancer
Cervical Cancer
Others
Market by End user
Hospitals
Independent Radiotherapy Centers
Cancer Research Institutes
Market by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Spain
Italy
Rest of Europe (RoE)
Asia-Pacific (APAC)
China
India
Japan
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa.
𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐅𝐫𝐞𝐞 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 @ https://www.meticulousresearch.com/download-sample-report/cp_id=5023
𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐑𝐞𝐩𝐨𝐫𝐭𝐬-
𝐈𝐧𝐭𝐞𝐫𝐯𝐞𝐧𝐭𝐢𝐨𝐧𝐚𝐥 𝐨𝐧𝐜𝐨𝐥𝐨𝐠𝐲 𝐌𝐚𝐫𝐤𝐞𝐭 by Procedure [Embolization (TARE, TACE), Ablation (Thermal Ablation (Microwave, RF Ablation))], Product [Embolization (SIR-Spheres, TheraSpheres)], Application (Liver, Lung, Breast), and End User - Global Forecast to 2025
https://www.meticulousresearch.com/product/interventional-oncology-market-4951/
𝐌𝐮𝐥𝐭𝐢𝐦𝐨𝐝𝐚𝐥 𝐈𝐦𝐚𝐠𝐢𝐧𝐠 𝐌𝐚𝐫𝐤𝐞𝐭 By Product (Equipment, Reagent, Software), Technology (PET-CT, SPECT-CT, PET-MRI), Application [Clinical (Oncology, Orthopedic, Cardiology), Research], End User (Hospitals, Diagnostic Centers, Academia)- Global Forecast to 2024
https://www.meticulousresearch.com/product/multimodal-imaging-market/
𝐀𝐛𝐨𝐮𝐭 𝐌𝐞𝐭𝐢𝐜𝐮𝐥𝐨𝐮𝐬 𝐑𝐞𝐬𝐞𝐚𝐫𝐜𝐡®
The name of our company defines our services, strengths, and values. Since the inception, we have only thrived to research, analyze and present the critical market data with great attention to details.
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, with the help of its unique research methodologies, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa regions.
With the meticulous primary and secondary research techniques, we have built strong capabilities in data collection, interpretation, and analysis of data including qualitative and quantitative research with the finest team of analysts. We design our meticulously analyzed intelligent and value-driven syndicate market research reports, custom studies, quick turnaround research, and consulting solutions to address business challenges of sustainable growth.
𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Meticulous Research™
chhagan yadav
+91 744-7780008
chhagan.y@meticulousresearch.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
